DK1005328T3 - Sammensætning omfattende findelte krystallinske partikler af budesonid - Google Patents
Sammensætning omfattende findelte krystallinske partikler af budesonidInfo
- Publication number
- DK1005328T3 DK1005328T3 DK98924697T DK98924697T DK1005328T3 DK 1005328 T3 DK1005328 T3 DK 1005328T3 DK 98924697 T DK98924697 T DK 98924697T DK 98924697 T DK98924697 T DK 98924697T DK 1005328 T3 DK1005328 T3 DK 1005328T3
- Authority
- DK
- Denmark
- Prior art keywords
- budesonide
- composition
- finely divided
- crystalline particles
- divided crystalline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9701956A SE9701956D0 (sv) | 1997-05-23 | 1997-05-23 | New composition of matter |
| PCT/SE1998/000908 WO1998052544A1 (en) | 1997-05-23 | 1998-05-15 | Composition comprising finely divided, crystalline particles of budesonide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1005328T3 true DK1005328T3 (da) | 2003-11-17 |
Family
ID=20407079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98924697T DK1005328T3 (da) | 1997-05-23 | 1998-05-15 | Sammensætning omfattende findelte krystallinske partikler af budesonid |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6346523B1 (da) |
| EP (1) | EP1005328B1 (da) |
| JP (1) | JP2001525850A (da) |
| KR (1) | KR100514971B1 (da) |
| CN (1) | CN1146406C (da) |
| AR (1) | AR015820A1 (da) |
| AT (1) | ATE246492T1 (da) |
| AU (1) | AU734763B2 (da) |
| BR (1) | BR9808812A (da) |
| CA (1) | CA2290538C (da) |
| DE (1) | DE69816997T2 (da) |
| DK (1) | DK1005328T3 (da) |
| EE (1) | EE03850B1 (da) |
| ES (1) | ES2205496T3 (da) |
| HU (1) | HUP0002212A3 (da) |
| ID (1) | ID24332A (da) |
| IL (1) | IL133098A (da) |
| IS (1) | IS5254A (da) |
| NO (1) | NO995540L (da) |
| NZ (1) | NZ500852A (da) |
| PL (1) | PL336902A1 (da) |
| PT (1) | PT1005328E (da) |
| SE (1) | SE9701956D0 (da) |
| SK (1) | SK158799A3 (da) |
| TR (1) | TR199902880T2 (da) |
| TW (1) | TW518236B (da) |
| WO (1) | WO1998052544A1 (da) |
| ZA (1) | ZA984127B (da) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0810853B1 (en) * | 1995-02-24 | 2004-08-25 | Elan Pharma International Limited | Aerosols containing nanoparticle dispersions |
| CN1192810C (zh) | 2000-03-03 | 2005-03-16 | 贝林格尔·英格海姆药物公司 | 通过反复的溶剂膨胀－收缩处理物料 |
| EP1354581A4 (en) * | 2000-12-26 | 2007-07-04 | Takeda Pharmaceutical | POROUS SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF |
| GB0106403D0 (en) * | 2001-03-15 | 2001-05-02 | Pharmaceutical Profiles | Labelling of dry powder formulations for inhalation |
| GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
| CA2456806C (en) | 2001-08-08 | 2011-10-18 | Brown University Research Foundation | Methods for micronization of hydrophobic drugs |
| DK1435916T3 (da) * | 2001-10-10 | 2006-08-21 | Boehringer Ingelheim Pharma | Pulverbearbejdning med tryksatte gasformige fluider |
| US20030129242A1 (en) * | 2002-01-04 | 2003-07-10 | Bosch H. William | Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
| GB0216562D0 (en) * | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
| US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
| CA2523035C (en) | 2003-05-22 | 2011-04-26 | Elan Pharma International Ltd. | Sterilization of dispersions of nanoparticulate active agents with gamma radiation |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
| US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| EP1730751B1 (en) * | 2004-03-12 | 2009-10-21 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | A magnetoresistive medium |
| US20090186088A1 (en) * | 2005-03-18 | 2009-07-23 | Nanomaterials Technology Pte Ltd | Inhalable drug |
| EP1904219A4 (en) | 2005-07-15 | 2011-07-27 | Map Pharmaceuticals Inc | METHOD FOR FORMING PARTICLES |
| EP1782839A1 (en) | 2005-11-03 | 2007-05-09 | Genetic S.p.A. | Sterilization process of Glucocorticosteroid by supercritical CO2 |
| US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| US20070178049A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
| US20070178051A1 (en) * | 2006-01-27 | 2007-08-02 | Elan Pharma International, Ltd. | Sterilized nanoparticulate glucocorticosteroid formulations |
| JP2009526860A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | 安定したコルチコステロイド混合物 |
| US8148377B2 (en) | 2007-02-11 | 2012-04-03 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
| US20100294986A1 (en) * | 2009-05-19 | 2010-11-25 | Massachusetts Institute Of Technology | Supercritical fluid facilitated particle formation in microfluidic systems |
| US20100298602A1 (en) * | 2009-05-19 | 2010-11-25 | Massachusetts Institute Of Technology | Systems and methods for microfluidic crystallization |
| CA2812263A1 (en) * | 2010-09-22 | 2012-03-29 | Map Pharmaceuticals, Inc. | Corticosteroid particles and method of production |
| CN102975731B (zh) * | 2012-04-24 | 2015-08-12 | 南车南京浦镇车辆有限公司 | 轨道车辆司机室骨架与车体的安装结构 |
| WO2021219230A1 (en) | 2020-04-30 | 2021-11-04 | Paolo Fiorina | Antiviral treatment |
| KR102567655B1 (ko) | 2020-11-13 | 2023-08-17 | 주식회사 비츠로이엠 | 진공커패시터 및 진공커패시터 제조 방법 |
| KR20230072023A (ko) | 2021-11-17 | 2023-05-24 | 주식회사 비츠로이엠 | 가변형 진공 커패시터의 나선형 전극 위치 결정구조 |
| KR20230072022A (ko) | 2021-11-17 | 2023-05-24 | 주식회사 비츠로이엠 | 가변형 진공 커패시터 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1282405C (en) | 1984-05-21 | 1991-04-02 | Michael R. Violante | Method for making uniformly sized particles from water-insoluble organic compounds |
| AU624421B2 (en) | 1988-10-05 | 1992-06-11 | Pharmacia & Upjohn Company | Finely divided solid crystalline powders via precipitation into an anti-solvent |
| GB9001635D0 (en) | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
| DE69112917T2 (de) | 1990-06-15 | 1996-05-15 | Merck & Co Inc | Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse. |
| SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
| ATE213946T1 (de) * | 1991-12-18 | 2002-03-15 | Formoterol und budesonide enthaltende zusammensetzung | |
| GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| SE9501384D0 (sv) | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
-
1997
- 1997-05-23 SE SE9701956A patent/SE9701956D0/xx unknown
-
1998
- 1998-05-15 ES ES98924697T patent/ES2205496T3/es not_active Expired - Lifetime
- 1998-05-15 CA CA002290538A patent/CA2290538C/en not_active Expired - Fee Related
- 1998-05-15 ID IDW991396A patent/ID24332A/id unknown
- 1998-05-15 US US09/091,453 patent/US6346523B1/en not_active Expired - Fee Related
- 1998-05-15 AU AU76800/98A patent/AU734763B2/en not_active Ceased
- 1998-05-15 BR BR9808812-2A patent/BR9808812A/pt not_active Application Discontinuation
- 1998-05-15 SK SK1587-99A patent/SK158799A3/sk unknown
- 1998-05-15 DK DK98924697T patent/DK1005328T3/da active
- 1998-05-15 EP EP98924697A patent/EP1005328B1/en not_active Expired - Lifetime
- 1998-05-15 ZA ZA984127A patent/ZA984127B/xx unknown
- 1998-05-15 WO PCT/SE1998/000908 patent/WO1998052544A1/en active IP Right Grant
- 1998-05-15 CN CNB988053381A patent/CN1146406C/zh not_active Expired - Fee Related
- 1998-05-15 NZ NZ500852A patent/NZ500852A/en unknown
- 1998-05-15 TW TW087107532A patent/TW518236B/zh not_active IP Right Cessation
- 1998-05-15 PT PT98924697T patent/PT1005328E/pt unknown
- 1998-05-15 HU HU0002212A patent/HUP0002212A3/hu unknown
- 1998-05-15 IL IL13309898A patent/IL133098A/xx not_active IP Right Cessation
- 1998-05-15 JP JP55028498A patent/JP2001525850A/ja not_active Ceased
- 1998-05-15 KR KR10-1999-7010785A patent/KR100514971B1/ko not_active IP Right Cessation
- 1998-05-15 TR TR1999/02880T patent/TR199902880T2/xx unknown
- 1998-05-15 EE EEP199900533A patent/EE03850B1/xx not_active IP Right Cessation
- 1998-05-15 PL PL98336902A patent/PL336902A1/xx unknown
- 1998-05-15 AT AT98924697T patent/ATE246492T1/de not_active IP Right Cessation
- 1998-05-15 DE DE69816997T patent/DE69816997T2/de not_active Expired - Lifetime
- 1998-05-22 AR ARP980102400A patent/AR015820A1/es not_active Application Discontinuation
-
1999
- 1999-11-12 NO NO19995540A patent/NO995540L/no not_active Application Discontinuation
- 1999-11-18 IS IS5254A patent/IS5254A/is unknown
-
2001
- 2001-11-06 US US09/992,940 patent/US6468994B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1005328T3 (da) | Sammensætning omfattende findelte krystallinske partikler af budesonid | |
| DK0954282T3 (da) | Fremstilling af partikler til inhalation | |
| DK0969816T3 (da) | Fremstilling af pulveragglomerater | |
| DK1056444T3 (da) | Stabile formede partikler af krystallinske organiske forbindelser | |
| IL136086A0 (en) | New composition of matter | |
| DK0911385T3 (da) | Stanolholdige sammensætninger | |
| DK1275387T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed | |
| DE69929799D1 (de) | Ultraviolettlicht absorbierende zusammensetzungen | |
| BR9509200A (pt) | Composição de matéria | |
| ID28471A (id) | Komposisi-komposisi binatu yang mengandung bahan-bahan pendispersi polialkilenaimina teralkoksilasi | |
| ID24486A (id) | Komposisi-komposisi oral dari levosimendan | |
| IS5267A (is) | Skammtaform af sertralíni sem losna seint | |
| ID16838A (id) | Komposisi dekafluoropentana | |
| DK1102747T3 (da) | Krystalformer af osenetant | |
| DK1077762T3 (da) | Fremgangsmåde til fremstilling af sfæriske oxidpartikler | |
| ID23429A (id) | Komposisi-komposisi sertralina yang larut | |
| DK0967202T3 (da) | Fotolyse af 7-dehydrocholesterol | |
| DE69513536D1 (de) | Zweikomponenten-klebstoffzusammensetzung | |
| DK1088010T3 (da) | Fremstilling af polyolefiner | |
| PL337612A1 (en) | Crystalline form of roxyfiban | |
| IS2179B (is) | Fjölbrigði af dófetilíði | |
| ID22516A (id) | Komposisi perekat jenis pralapis | |
| ID23295A (id) | Komposisi bedak bubuk talek | |
| AU3103399A (en) | Lcb1 subunit of serine palmitoyltransferase | |
| GB9722171D0 (en) | Compositions for the entrapment of airborne particles |